Stockreport

Neurona Therapeutics Raises $102 Million to Fuel NRTX-1001 Phase 3 EPIC Epilepsy Trial and Advance Regenerative Cell Therapy Pipeline [Yahoo! Finance]

UCB SA UNSP/ADR  (UCBJY) 
NASDAQ:AMEX Investor Relations: ucb.com/investors
PDF Capital, Viking Global Investors, and Cormorant Asset Management, follows continued positive clinical signal from Neurona's ongoing Phase 1/2 clinical trial - The roun [Read more]